Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
Portfolio Pulse from
Ironwood Pharmaceuticals (IRWD) reported Q3 earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.09 per share and down from $0.12 per share a year ago.
November 07, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ironwood Pharmaceuticals reported Q3 earnings of $0.02 per share, missing the expected $0.09 and showing a decline from $0.12 a year ago.
The earnings miss and year-over-year decline in earnings per share are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100